Paperpal Prime Logo

Journal of Neuromuscular Diseases : Impact Factor & More

eISSN: 2214-3602pISSN: 2214-3599

Key Metrics

CiteScore
5.5
H-Index
34
Impact Factor
< 5
SJR
Q1Neurology
SNIP
1.3
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Neuromuscular Diseases

Journal of Neuromuscular Diseases Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher IOS PRESS
Language English
Frequency Annual
General Details
LanguageEnglish
FrequencyAnnual
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Neuromuscular Diseases ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Neuromuscular Diseases

Total energy expenditure assessed by doubly labeled water in patients with myotonic dystrophy type 1: Associations with body composition and functional status
  • 5 Aug 2026
  • Journal of Neuromuscular Diseases
Prospective study of efgartigimod in severe myasthenia gravis exacerbations requiring ventilatory or enteral support
  • 4 Aug 2026
  • Journal of Neuromuscular Diseases
Clinical and functional outcome measures in LAMA2-related muscular dystrophy and SELENON-related myopathy; a 1.5-year natural history study
  • 1 Aug 2026
  • Journal of Neuromuscular Diseases
Energy expenditure and the accuracy of predictive equations in myotonic dystrophy type 1
  • 31 Jul 2026
  • Journal of Neuromuscular Diseases
Expanding the phenotypic spectrum of COL6-related diseases: Motor neuropathy-like and neuromyopathy associated with COL6A3 c.7447A>G
  • 28 Jul 2026
  • Journal of Neuromuscular Diseases
Cardiac autonomic dysfunction is associated with advanced stage, fast progression and poor survival in amyotrophic lateral sclerosis
  • 25 Jul 2026
  • Journal of Neuromuscular Diseases
Total energy expenditure assessed by doubly labeled water in patients with myotonic dystrophy type 1: Associations with body composition and functional status
  • 5 Aug 2026
  • Journal of Neuromuscular Diseases
Prospective study of efgartigimod in severe myasthenia gravis exacerbations requiring ventilatory or enteral support
  • 4 Aug 2026
  • Journal of Neuromuscular Diseases
Clinical and functional outcome measures in LAMA2-related muscular dystrophy and SELENON-related myopathy; a 1.5-year natural history study
  • 1 Aug 2026
  • Journal of Neuromuscular Diseases
Energy expenditure and the accuracy of predictive equations in myotonic dystrophy type 1
  • 31 Jul 2026
  • Journal of Neuromuscular Diseases
Expanding the phenotypic spectrum of COL6-related diseases: Motor neuropathy-like and neuromyopathy associated with COL6A3 c.7447A>G
  • 28 Jul 2026
  • Journal of Neuromuscular Diseases
Cardiac autonomic dysfunction is associated with advanced stage, fast progression and poor survival in amyotrophic lateral sclerosis
  • 25 Jul 2026
  • Journal of Neuromuscular Diseases

FAQs on Journal of Neuromuscular Diseases